Patterns Of Haematological Biomarker in cervical cancer patients and its association with its covariates
- Conditions
- Health Condition 1: C539- Malignant neoplasm of cervix uteri, unspecified
- Registration Number
- CTRI/2023/06/053636
- Lead Sponsor
- Vardhman Mahavir Medical College
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Patients with positive biopsy report of cervical carcinoma at any stage of the disease
Patients who donâ??t have a record of their Pre Treatment Neutrophil lymphocyte Ratio (NLR).
Severely ill patients not able to converse.
Patients suffering from sepsis.
Patients with a positive biopsy for blood cancer.
Patients with a history of tuberculosis.
Patients with severe wounds.
Any other severe inflammation except cervical cancer.
Patients with active liver disease, including those with primary biliary cirrhosis and unexplained persistent liver function abnormalities.
Any medication or indication that may interfere with the interpretation of study results and, in the judgment of the study personnel, would make the subject inappropriate for inclusion.
Patients with history of severe allergies.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To find mean Neutrophil Lymphocyte Ratio(NLR) among cervical cancer patients.Timepoint: 9 weeks
- Secondary Outcome Measures
Name Time Method To check association of Neutrophil Lymphocyte Ratio(NLR) with Sociodemographic, lifestyle & reproductive factors among cervical cancer patients.Timepoint: 9 weeks;To compare Neutrophil Lymphocyte Ratio(NLR) among various stages of cervical cancer.Timepoint: 9 weeks